Treatment Of Depression – Tenil Fri, 11 Jun 2021 02:40:48 +0000 en-US hourly 1 Treatment Of Depression – Tenil 32 32 Young Australians and COVID-19: More depression and anxiety, but less alcohol-related harm Thu, 10 Jun 2021 22:00:00 +0000

Young Australians experienced increased depression and anxiety during COVID-19 restrictions in 2020 but consumed less alcohol, according to a new report from the National Drug and Alcohol Research Center (NDARC) at UNSW Sydney .

Worryingly, the increase in their mental health problems has not been offset by a greater demand for help from mental health professionals.

The researchers used survey data from 1,927 young people – with a median age of 22 – as part of the Australian Parental Supply of Alcohol Longitudinal Study (APSALS) cohort. They found that half of the cohort considered their mental health to have deteriorated in May-June 2020, compared to August 2019-March 2020.

“Young people may be disproportionately affected by certain stressors associated with the pandemic, such as the reduction of occasional working hours and the disruption of other structured activities such as higher education,” explains Emily Upton, research fellow at NDARC and clinical psychologist.

The report found that despite the rise in generalized anxiety and depression, there had been no increase in the number of young people seeking mental health support from medical professionals.

“Young people tend to have little involvement in mental health treatment and rely more on self-reliance strategies to deal with mental health issues,” Upton explains.

Delay in young people’s access to support

The report found that although the Australian government has introduced initiatives to increase access to mental health support during the pandemic, there may be a delay in young Australians accessing this support.

“Cost is a major barrier to accessing treatment for young people. The reduction in income during the pandemic may be a factor in the low rate of seeking help and, although government discounts are available, these do not cover the full cost of psychological treatment, ”Ms. Upton said.

In another report using the same APSALS survey data, researchers found that alcohol use among young people during the COVID-19 pandemic had declined.

Dr Philip Clare, biostatistician at The Prevention Research Collaboration, University of Sydney, said overall alcohol consumption among young people during the May and June 2020 restrictions has declined. “It is down 17% from February 2020, and there has been a 34% drop in the rate of alcohol-related harm.”

The report found that the changes in consumption appear to be driven by the COVID-19 restrictions.

Increase in consumption “virtually”

“Young people generally consume more alcohol outside the home, so we would expect alcohol consumption to decrease during COVID-19 restrictions. However, we have seen an increase in alcohol consumption alone and consumption “virtually” with others, ”says Dr. Clare.

Likewise, the decrease in alcohol-related harms may be due to the fact that alcohol consumption was more likely to occur alone or “virtually” with others due to the need to isolate oneself, this which reduces the risk of harm such as arguments with strangers, traffic accidents. “

The report stresses that it is also important to understand alcohol-related trends among young people so that relevant harm reduction strategies can be implemented.

“Although alcohol consumption and harms have decreased, we may see an increase in the future due to loss of tolerance,” said Dr Clare.

Read Ms Emily Upton’s APSALS report.

Read Dr Philip Clare’s APSALS report.

People can access free, confidential advice on alcohol and other drugs by calling the National Alcohol and Other Drugs Hotline – 1800 250 015.

Source link

]]> 0
Drug commonly used as an antidepressant helps fight cancer in mice Thu, 10 Jun 2021 09:02:23 +0000

PICTURE: Shirley Xi Wang, Lili Yang, and Ryan Yu-Chen Wang found that mice became more able to fight melanoma and colon tumors when treated with MAOIs. view After

Credit: UCLA Large Stem Cell Research Center

A class of drugs called monoamine oxidase inhibitors are commonly prescribed to treat depression; the drugs work by increasing the levels of serotonin, the brain’s “happiness hormone”.

A new study by researchers at UCLA suggests that these drugs, commonly known as MAOIs, may have another health benefit: helping the immune system attack cancer. Their results are reported in two articles, which are published in the journals Scientific immunology and Nature Communication.

“MAOIs have never been linked to the immune system’s response to cancer before,” said Lili Yang, lead author of the study and member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA . “What’s particularly exciting is that this is a very well-researched and safe class of drugs, so reusing it for cancer isn’t as difficult as developing a completely new drug on it. would be.”

Recent advances in understanding how the human immune system naturally searches for and destroys cancer cells, as well as how tumors try to evade this response, have led to new cancer immunotherapies – drugs that stimulate the activity of the immune system in an attempt to fight cancer.

In an effort to develop new immunotherapies against cancer, Yang and his colleagues compared immune cells from melanoma tumors in mice to immune cells from animals without cancer. The immune cells that had infiltrated the tumors had a much higher activity of a gene called monoamine oxidase A, or MAOA. The corresponding MAOA protein, called MAO-A, controls serotonin levels and is targeted by MAOI drugs.

“For a long time, people have theorized about the crosstalk between the nervous system and the immune system and the similarities between the two,” said Yang, who is also an associate professor of microbiology, immunology and molecular genetics at UCLA. and member of the UCLA Jonsson Comprehensive Cancer Center. “So it was exciting to find out that MAOA was so active in these tumor-infiltrating immune cells.”

Next, the researchers studied mice that did not produce MAO-A protein in immune cells. Scientists found that these mice better controlled the growth of melanoma and colon tumors. They also found that normal mice became more able to fight off these cancers when treated with MAOIs.

Investigating the effects of MAO-A on the immune system, researchers found that T cells – immune cells that target cancer cells for destruction – produce MAO-A when they recognize tumors, which shrinks their ability to fight cancer.

This discovery places MAO-A among a growing list of molecules known as immune checkpoints, which are molecules produced as part of a normal immune response to prevent T cells from overreacting or overreacting. attack healthy tissue in the body. Cancer is known to harness the activity of other previously identified immune checkpoints to evade attacks by the immune system.

In the Scientific immunology article, scientists report that MAOIs help block MAO-A function, which helps T cells overcome immune checkpoint and fight cancer more effectively.

But drugs also have a second role in the immune system, Yang found. Unwanted immune cells known as tumor associated macrophages often help tumors evade the immune system by preventing anti-tumor cells, including T cells, from mounting an effective attack. High levels of these tumor-associated immunosuppressive macrophages within a tumor have been associated with poorer prognoses for people with certain types of cancer.

But the researchers found that MAOIs block immunosuppressive macrophages associated with tumors, effectively destroying a tumor line of defense against the human immune system. This finding is reported in the Nature Communication paper.

“It turns out that MAOIs appear to both directly help T cells do their job and prevent tumor-associated macrophages from slowing down T cells,” Yang said.

Combine MAOIs with existing immunotherapies

Yang said she suspected MAOIs might work well in concert with a type of cancer immunotherapies called immune checkpoint blocking therapies, most of which work by targeting immune checkpoint molecules on the surface. immune cells. This is because MAOIs work on MAO-A proteins, which are inside cells and work differently from other known immune checkpoint molecules.

Studies in mice have shown that one of the three existing MAOIs – phenelzine, clorgyline or mocolobemide – alone or in combination with a form of immune checkpoint blocking therapy known as PD-1 blockers, could stop or slow the growth of colon cancer. and melanoma.

Although they did not test the drugs in humans, the researchers analyzed clinical data from people with melanoma, colon, lung, cervical and pancreatic cancer; they found that people with higher levels of MAOA gene expression in their tumors had, on average, shorter survival times. This suggests that targeting MAOA with MAOIs could potentially help treat a wide range of cancers.

Yang and coworkers are already planning additional studies to test the effectiveness of MAOIs in stimulating the response of human immune cells to various cancers.

Yang said MAOIs could potentially act on both the brain and immune cells of cancer patients, which are up to four times more likely than the general population to experience depression.

“We suspect that reuse of MAOIs for cancer immunotherapy may provide patients with both antidepressant and anti-tumor benefits,” she said.

The experimental combination therapy in the study has been used in preclinical testing only and has not been studied in humans or approved by the Food and Drug Administration as safe and effective for use in humans. The newly identified therapeutic strategy is covered by a patent application filed by the UCLA Technology Development Group on behalf of the Regents of the University of California, with Yang, Xi Wang and Yu-Chen Wang as co-inventors.


The research was supported by Stop Cancer, the Broad Stem Cell Research Center Rose Hills Foundation Innovator Grant and Stem Cell Training Program, the UCLA Jonsson Comprehensive Cancer Center and the Broad Stem Cell Research Center Ablon Scholars Program, the Magnolia Council of Tower Cancer Research Foundation and the National Institutes of Health, including a Ruth L. Kirschstein National Research Service Award.

Warning: AAAS and EurekAlert! are not responsible for the accuracy of any press releases posted on EurekAlert! by contributing institutions or for the use of any information via the EurekAlert system.

Source link

]]> 0
What is nutritional psychiatry? For starters, it’s delicious Wed, 09 Jun 2021 14:00:00 +0000

“We are human,” says Dr Naidoo. “Instead of judging yourself if you have a piece of cake, take advantage of it and move on. People shouldn’t hang on to diet war rules like “you can never eat bread or cake” or anything. In other words, Pizza Fridays won’t make or break your body’s microbiome, and it certainly shouldn’t break your mind. With that said, here are some steps you can take to support a healthy eating-mood relationship.

Limit sugar (including artificial sweeteners) and processed foods.

Many processed foods combine “empty” calories with other chemicals and additives, like colors, preservatives, fillers, and sugary ingredients that can cause inflammation, which “makes our brains depressed, anxious, and so on. blur “, explains Drew ramsey, MD, clinical psychiatrist, professor, author and expert in nutritional psychiatry. “It’s pretty clear at this point.”

A sugar-fed gut microbiome craves sugar. Sugar causes inflammation and is linked to lower levels of BDNF, a protein that helps our brains adapt to stress. Artificial sweeteners like aspartame and saccharin are also on the banned list, due to potentially toxic effects on mood-regulating neurotransmitters and chemical synthesis in the brain. I’m sad to say that simple carbohydrates, like white rice and pasta, fall under the category of sugar; they quickly break down into glucose (sugar) in the body. Much of their nutritional value, like fiber and vitamins, has also been removed.

Add lots of colorful vegetables, legumes and leafy greens.

You may already know the old adage: “eat the rainbow”. Replace unnecessary inflammatory or nutritionally neutral foods with dark chocolate, peppers, citrus fruits, berries, leafy greens, lentils, asparagus, broccoli, berries, you get the idea. These foods contain healthy fiber for the microbiome and mood-enhancing vitamins and minerals, such as iron, folic acid, magnesium, zinc, and vitamins A and B.

Incorporate probiotics.

Our digestive tract is home to around 100,000 billion bacteria and microorganisms, which play a major role in our health. Eating active cultures helps to crowd out unhealthy microorganisms and increases the healthy flora in our microbiome, which improves mood and our overall health. Foods like kefir, yogurt with no added sugar, kimchi, sauerkraut, miso, tempeh, and buttermilk all contain bacteria that are important for gut health. Probiotics are best supported by prebiotics: foods like oats, alliums, garlic, apples, and beans.

Take advantage of omega-3s, limit saturated fat, and go for lean protein.

Fish like sardines, salmon, tuna, and mackerel are loaded with omega-3 fatty acids, which reduce inflammation in the brain and can be a great source of vitamin D. Avocados and olive oil olive help complete the list of nutrient rich fats. . Lean beef, shellfish and poultry are high in iron, a mood booster. Grass-fed beef, chia seeds and nuts also contain omega-3s. In fact, “nuts are a perfect blend of carbohydrates, protein, fiber and fat,” says Dr. Ramsey.

Nutritional psychiatrists also recommend limiting saturated fats, like shortening and margarine, and eliminating trans fats completely.

Cut back on caffeine and alcohol.

Both play a role in anxiety, writes Dr Naidoo in It’s your brain on food. “Anxious people sleep less well if they drink alcohol regularly”, despite the fact that “drinking can relax them in the moment”. This means no more than one drink per day for women and two per day for men.

Caffeine, despite this morning rush, overstimulates the threat processing region of the brain and decreases function in the area that helps regulate anxiety. Instead of giving up your brew altogether, cut it down and try incorporating calming chamomile or turmeric tea into your drink list. Also, be sure to drink plenty of water: about four to six glasses a day, more if you sweat and exercise.

How does food supplement other mental health treatments?

Nutritional psychiatrists incorporate food into broader treatment plans, which may include medication, talk therapy, acupuncture, yoga, exercise, and more. “It’s really about putting all of these pieces together,” says Dr Naidoo. In other words, food helps, but it shouldn’t be seen as a quick fix.

“If someone says celery juice can cure depression, that doesn’t help,” agrees Dr Ramsey, who has seen many patients injured because they thought their very restrictive diet would cure them. “Having said that, I think all American doctors and psychiatrists agree that it would be best if our patients were to eat really healthy, unprocessed foods. Not that it will cure all mental illnesses, but it certainly helps improve brain health and alleviate symptoms. “

Source link

]]> 0
How your phone can predict depression and lead to personalized treatment Tue, 08 Jun 2021 22:06:21 +0000

According to the National Alliance on Mental Illness and the World Health Organization, depression affects 16 million Americans and 322 million people worldwide. New evidence suggests that the COVID-19 pandemic is further worsening the prevalence of depression in the general population. With this trajectory, it is evident that more effective strategies are needed for therapies that address this critical public health problem.

In a recent study, published in the June 9, 2021 online edition of Translational Psychiatry Nature, researchers at the University of California, San Diego School of Medicine used a combination of modalities, such as measuring brain function, cognition, and lifestyle factors, to generate individualized predictions depression.

Jyoti Mishra, PhD, is the lead author of the study, director of NEATLabs and assistant professor in the Department of Psychiatry at UC San Diego School of Medicine.

The machine learning and personalized approach took into account several factors related to an individual’s subjective symptoms, such as sleep, exercise, diet, stress, cognitive performance and brain activity.

“There are different reasons and underlying causes of depression,” said Jyoti Mishra, PhD, lead author of the study, director of NEATLabs and assistant professor in the Department of Psychiatry at UC San Diego School of Medicine. . “Put simply, today’s healthcare standards are all about asking people how they feel and then writing a prescription for drugs. These first-line treatments have been shown to be only mild to moderately effective in large-scale trials.

“Depression is a multifaceted illness, and we need to approach it with personalized treatment, whether it’s therapy with a mental health professional, more exercise, or a combination of ‘approaches.”

The month-long study collected data from 14 participants with depression using smartphone apps and wearable devices (such as smartwatches) to measure the mood and lifestyle variables of the patient. sleep, exercise, diet and stress, and has associated them with cognitive assessments and electroencephalography, using scalp electrodes to record brain activity.

The goal was not to make comparisons between individuals, but to model predictors of daily fluctuations in each person’s depressed mood.

Researchers have developed a new machine learning pipeline to systematically identify distinct predictors of bad mood in each individual.

For example, exercise and daily caffeine consumption appeared to be strong predictors of mood for one participant, but for another, it was sleep and stress that were more predictive, while in a third topic, the main predictors were brain function and cognitive responses to rewards. .

“We shouldn’t approach mental health as one size fits all. Patients will benefit from a more direct and quantified insight into how specific behaviors may fuel their depression. Clinicians can use this data to understand how their patients might feel and better integrate medical and behavioral approaches to improve and maintain mental health, ”said Mishra.

“Our study shows that we can use readily available technology and tools, such as mobile phone apps, to collect information from people with or at risk for depression, without significant burden to them, and then use that information to design personalized treatment plans. . “

Mishra said the next steps are to examine whether personalized treatment plans driven by data and machine learning are effective.

“Our findings may have broader implications than depression. Anyone seeking greater well-being could benefit from information quantified from their own data. If I don’t know what’s wrong, how do I know how to feel better? “

Co-authors include: Rutvik Shah, Gillian Grennan, MariamZafar-Khan, Fahad Alim, Sujit Dey, all with UC San Diego; and Dhakshin Ramanathan with UC San Diego and the VA San Diego Medical Center.

The research was funded, in part, by the University of California at San Diego and startup grants from the Center for Mental Health Technology at UC San Diego and the Sanford Institute for Empathy and Compassion.

Disclosure: Shah, Dey and Mishra have filed an invention disclosure for “Personalized Depressed Mood Machine Learning Using Wearable Devices.”

Source link

]]> 0
You missed the mark | | Tue, 08 Jun 2021 04:00:00 +0000

Dear Annie: As someone who has suffered from clinical depression all my life, I have the impression that your answer was lacking. What “Blessed” describes is not much different from the advice of some well-meaning but mistaken people that all depressed people can get by on their own. There are different types of depression and depressive episodes.

Blessed appears to have gone into her depression after her divorce. I applaud her for doing all she could to help her own mental state. However, for those who are clinically depressed and those with mood disorders, their depression was not caused by a life event. This depression is not the one that goes away with a simple improvement in personal habits.

The treatment needed for a person with clinical depression is often psychological counseling along with antidepressant medication, as well as a lot of “tips” that those who try to be helpful offer. Even with all of this, it’s still a struggle.

I am sad that your response missed the opportunity to clear this up for those with the “blessed” mindset. The clinically depressed deserve the dignity of understanding. – Misunderstood by many

Dear misunderstood: Thank you for your honest and kind e-mail. Hope this helps others who are suffering.

Source link

]]> 0
Orphan drug status sought for ketamine as a potential treatment for ALS Mon, 07 Jun 2021 12:00:49 +0000

PharmaTher has filed an application with the United States Food and Drug Administration (FDA) requesting that ketamine be designated as an orphan drug as a potential treatment for amyotrophic lateral sclerosis (ALS).

Orphan drug status is granted by the FDA to encourage the development of therapies for conditions that affect fewer than 200,000 people in the United States. receive regulatory approval.

PharmaTher recently entered into an exclusive license agreement with the University of Kansas to develop and eventually commercialize ketamine, approved as a dissociative agent [psychedelic] anesthetic and for treatment-resistant depression, also to treat ALS. He plans to potentially open a Phase 2 clinical trial of ketamine as a treatment for ALS later this year.

“Ketamine has enormous potential not only for mental illnesses and painful disorders, but also for neurodegenerative diseases such as ALS,” Fabio Chianelli, CEO of PharmaTher, said in a press release.

“Our orphan drug application to the FDA for ketamine to treat this potentially fatal disease complements our patent portfolio which seeks to protect the proposed method of use and assay claims of ketamine for ALS,” added Chianelli. “[O]Our intention to seek orphan drug designation is to take advantage of the regulatory and accelerated clinical development incentives offered by the FDA for drugs reused in the treatment of rare diseases.

While ketamine is primarily used as an anesthetic, work from researchers at the University of Kansas suggests that it may also be an effective treatment for ALS.

Their preclinical studies showed that ketamine preserves muscle function, potentially increasing life expectancy when given in the early stages of muscle decline, the company reported.

In patients with ALS, elevated levels of glutamate, a chemical messenger, in the brain and spinal cord produce an overwhelming activation of nerve cells which is toxic. The activation of these nerve cells by glutamate takes place in part by the N-methyl-D-aspartate (NMDA) receptors. Ketamine indirectly blocks these receptors to potentially inhibit the toxicity of glutamate.

Patients with ALS also have high levels of D-serine and low levels of dopamine. Ketamine can decrease D-serine levels and partially activate dopamine receptors.

Overall, these mechanisms contribute to the neuroprotective effects of ketamine, which may enhance the function of damaged motor neurons in ALS, PharmaTher said.

To date, three drugs have been approved by the FDA to treat ALS, and each has marginal effects in slowing the course of the disease and helping patients survive, the company noted. Therefore, there is an urgent need to develop more effective therapies for ALS.

PharmaTher also plans to study ketamine as a treatment for Parkinson’s disease if it is cleared by the FDA for clinical testing.

“We are working with our clinical and regulatory advisors to prepare our clinical development plan and study protocol… to conduct a potential Phase 2 clinical study in patients with ALS this year,” said Chianelli.

Source link

]]> 0
U of S is researching therapy options online for staff Sun, 06 Jun 2021 15:43:11 +0000

The university has issued a call for tenders for online cognitive behavioral therapy services for approximately 6,000 staff and their dependents.

Content of the article

The University of Saskatchewan is considering virtual therapy to meet staff demand for mental health services.

The school called for tenders last week for online cognitive behavioral therapy services for about 6,000 university staff and their dependents.

“Our intention is to increase our investment in promoting and preventing things to support employees and their families,” said Director of Wellness and Total Rewards Timothy Beke.

The service, which could go live as early as August, would involve stand-alone online therapy offered through an interface such as a digital app.

It would be intended for staff with mild to moderate anxiety, depression, insomnia, or other health issues as a convenient and timely resource, although it is not a substitute for more personalized services.

No vendor has been selected, but the program will adapt at its own pace and seek to steer people away from harmful thought patterns to respond to stressors in a more positive way, according to wellness manager Carine Waldbauer.


Content of the article

“Offer it in a the virtual space makes it accessible to faculty and staff wherever they are, ”said Waldbauer. “If they’re working from home, if they’re not in the office, if they’re out of province, it’s a tool they and their dependents could use at any time.

The university is gearing up for a ‘transitional’ fall semester as the province plans to remove public health restrictions that have remained in place since March 2020.

Waldbauer said a summer 2020 poll found many were looking for more support for their mental and physical health. Many of the 15 percent of staff and faculty who responded said they were struggling to find work-life balance as the geographic divide between office and home began to blur.

Long before the pandemic, mental health was the “biggest issue” among staff submitting claims, Beke said. He and Waldbauer have suggested that this could be the result of growing awareness and reduced stigma around mental health, but the exact causes remain unclear.

The university launched a wellness plan in 2017, and Beke said supports have been stepped up in subsequent years.

Academics have suggested that cognitive behavioral therapy would be a good option for people with moderate to moderate depression or anxiety, he said.

“We were encouraged by the fact that if we were to do something in the area of ​​mental health it would be one of the best investments.”

He said the specific details of how it works will depend on which vendor is ultimately selected.


Content of the article

More needs to be done to identify the causes of stress at work, he added.

“I feel like in mental health we have things classified – anxiety, depression. But you keep digging deeper. What are the underlying causes, the drivers? “

News seems to fly to us faster all the time. From COVID-19 updates to politics and crime and everything in between, it can be hard to keep pace. With that in mind, the Saskatoon StarPhoenix has created an Afternoon Headlines newsletter that can be delivered to your inbox daily to help you stay on top of the most important news of the day. Click here to subscribe.


Postmedia is committed to maintaining a lively but civil discussion forum and encourages all readers to share their views on our articles. Comments may take up to an hour of moderation before appearing on the site. We ask that you keep your comments relevant and respectful. We have enabled email notifications. You will now receive an email if you receive a reply to your comment, if there is an update to a comment thread that you follow, or if a user that you follow comments. Check out our community guidelines for more information and details on how to adjust your email settings.

Source link

]]> 0
Stories, Anxiety, Depression and the Present | Notice Sat, 05 Jun 2021 14:00:00 +0000

I like a good story. I love it even more when you can hear the story told by a masterful storyteller. It can get better. When you have two master storytellers together and they scale the stories. “I haven’t been to many rivers in the state, but the Santee River is certainly quite enough here near the coast.” “I have walked pretty much every river in the state and you’re right, the Santee is pretty.” “When I played football we trained six days a week and on Sunday afternoons some of us would get together for informal practice.” “We trained six days a week and on Sunday we did a ten mile run and an informal scrum. We won the state championship that year.

See how easy it is to increase the stake in a conversation? A lot of these conversations are fun. A great story can get much better with just a little embellishment. A bad story can also be a lot worse.

A friend of mine can step in and hijack a conversation in a minute. If you have been to a park, it has been to several national parks nearby. You exercised; he is training for a triathlon. If the pollen bothers you, don’t worry; he has been in intensive care for 80 days.

What’s interesting about my friend is that I don’t know what kind of job he has. I only see him about once a year. He could come and tell a fascinating story about building a power plant in Equatorial Africa or installing a solar panel on top of Mt. Everest. Most of the time he just waits for you to have a story and then he can outdo it.

Its strong point is to suck oxygen from the room with its health stories. Although he travels the world and does everything else, he has the worst health problems on earth. I contribute most of these illnesses to his storytelling ability. You can’t look at it and know that something is wrong. Most of the time, it is cured by a combination of voodoo, aromatherapy, holistic medicine, and special herbs combined with essential oils.

This year he stopped to give his take on life in the present. It can outperform anyone with depression or anxiety. He’s just living in the present now. This can be done without any of its usual disease remedies. He must have studied psychiatry last year. We’ve heard of worrying about the past (depression) and worrying about the future (anxiety) and how it keeps its mind focused on the present. Talk about sucking all the oxygen out of the room. After he finished recounting his past problems and fears for the future, I thought there could be no more hope for him. One guy said, “He’s got to buy Prozac, Valium, and 50 gallon barrel vodka.” No one even came close to having a story to top it off.

Now he’s living in the present. He only thinks of what he can do at this precise moment. Apparently he doesn’t care. His new mental state allows him to lead an idyllic carefree life.

I miss the stories he told a bit. Living in the present can have its benefits, but the stories are not so good. Worrying about the future probably affects everyone, but worrying about a meteor landing in the Atlantic Ocean and producing a 200-foot-high tidal wave sweeping everything from Charleston to St. Louis Missouri is a much better story.

Source link

]]> 0
Samaritan relaunches outpatient mental health program Fri, 04 Jun 2021 23:49:42 +0000

Samaritan Health Services has reopened the outpatient partial inpatient psychiatric program at the Good Samaritan Regional Medical Center campus.

The program was initially launched in early 2020, then was suspended due to the COVID-19 pandemic. It is located next to the inpatient unit of Samaritan Mental Health, which continues to serve patients who require inpatient care as part of their treatment.

Samaritan’s program offers group therapy, adult and life skills education, medication management, and other supports to people who need comprehensive – but not inpatient – treatment for their condition. mental or emotional health.

“Patients in the partial hospitalization program can maintain their independence and fulfill their personal responsibilities while receiving treatment,” said James Douglas, MD, medical director of Samaritan Mental Health. “These patients spend the day in the program, but they live at home and return to the community each evening. “

The program operates weekdays from 9 a.m. to 3:30 p.m. Patients may be admitted to the program by their primary care provider, mental health therapist or local emergency department – or they may be admitted after hospitalization. .

Each cohort is limited to eight patients, due to COVID-19 precautions. It is expected that future cohorts will be larger once the pandemic is over.

The partial hospitalization is the latest of several Samaritan initiatives aimed at addressing mental and behavioral health needs in Benton, Lincoln and Linn counties. Other programs and services include:

  • Behavioral health specialists integrated into the primary care clinics in the Samaritan service area. These specialists work with patients to achieve their goals of living healthy lives. They help patients deal with mental and psychological issues that lead to health issues like drug addiction, sleep loss, anxiety, and depression.
  • Residency training programs in adult and child psychology and psychiatry. These programs produce new clinicians, some of whom join Samaritan full-time upon completion of their training.
  • Location of mental health services at the Boys & Girls Club in Corvallis, as well as the Samaritan Integrated Pediatric Clinic at this facility.
  • Partnered with Benton County to provide treatment for youth 17 and under who present to the emergency department at Good Samaritan Regional Medical Center with threats of suicide.
  • Behavioral health nurses and specialists who see patients in the emergency department and in the inpatient units of the GSRMC. These nurses and specialists are trained to help patients and the medical team develop a treatment plan, and they follow up with the patient to ensure that they are successful on the plan.
  • A telepsychiatry program connecting mental health professionals from Samaritan to Corvallis with clinicians in remote communities for patients requiring consultation.

More information is available at or 541-768-4839.

Source link

]]> 0
Data reveals racial and ethnic disparities in mental health diagnoses Fri, 04 Jun 2021 19:35:21 +0000

Key points to remember

  • New report reveals discrepancies in mental health diagnoses in the United States
  • Asian patients, in particular, were much less likely to be diagnosed with depression or anxiety than white patients.
  • Experts say these trends highlight barriers to caring for people of color.

The diagnosis of anxiety or depression during a primary care visit may not depend solely on your mental health condition. New Analysis Finds Large Disparities In Getting A Mental Health Diagnosis Across Races And Ethnicities In The United Statessese

An Athenahealth analysis of patient visits to primary care providers (PCP) in 2020 found that although anxiety and depression are “strikingly” in more than 24 million patients, the diagnosis of conditions varied widely between patients. demographic groups.

Many experts say this data points to underlying disparities in mental health care in the United States. After all, a patient is diagnosed with a disorder when they feel comfortable or able to express their mental health symptoms with a PCP.

Overall, white patients were more likely to discuss their mental health with PCPs, and therefore receive a diagnosis if needed, than those of all other racial groups. The gap for Asian patients was particularly wide: they were 227% and 213% less likely to be diagnosed with anxiety or depression, respectively, than whites.

“We cannot examine racial disparities without recognizing that our country’s systems were built to serve the white majority, and the healthcare system is no exception,” Kelly Yang, BS, medical student and researcher at Albert Einstein College of Medicine in New York, says Verywell. She adds that factors such as stigma and the lack of Black, Indigenous and Colored (BIPOC) healthcare professionals perpetuate these inequalities.

How Race and Ethnicity Impact Your Health Care

The Athenahealth study followed more than 24 million people over an 8-month period, between May and December of last year. Patients were considered to be suffering from anxiety or depression if at least one PCP visit led to a diagnosis. Demographic trends in the diagnosis of depression and anxiety disorders included:

  • Women were more than one and a half times more likely than men to be diagnosed with anxiety disorder or major depression
  • Patients aged 51 to 70 were the most likely to be diagnosed with anxiety
  • Patients aged 71 to 80 were the most likely to be diagnosed with depression
  • The more chronic health conditions you had, the more likely you were to be diagnosed with either of these conditions.sese

The research was inspired by a Center for Disease Control and Prevention (CDC) investigative report conducted in June 2020. The CDC found that American adults suffered from more anxiety and depression during the pandemic, compared to younger adults. and Hispanic / Latino people feeling the brunt of it.sese

Trends in gender, age, and medical history can be at least partially explained by existing evidence. For example, women, in general, are more likely to talk about mental health issues with their PCP and to seek help.

But racial and ethnic trends highlight barriers to care. In the study, white patients were significantly more likely to be diagnosed with depression or anxiety than black, Hispanic / Latino and especially Asian patients.

Compared to Asians, in particular, 7.2% and 4.7% of white patients were diagnosed with anxiety and depression, respectively. In comparison, Asian patients were only diagnosed at rates of 2.2% and 1.5%.

Disparities in mental health care in Asia

When considering these rates, some might assume that Asian patients just don’t struggle as much with depression and anxiety. But that’s far from the reality, says Yang.

In a 2019 study, Yang and her colleagues found that while Asians and whites may perceive their need for mental health care at different rates, this does not explain the large gap between those diagnosed and treated.seConcretely :

  • 87.1% of White respondents with a perceived need for mental health care received it, compared to 80% of Asians with a perceived need
  • 53.3% of Whites reporting severe psychological distress received mental health treatment versus 28.9% of Asians reporting the same distress
  • 70% of white patients with a major depressive episode in the past year received mental health treatment, compared to 35.3% of their Asian counterparts

Why are Asian respondent rates consistently lower? When Yang and her colleagues asked Asian respondents about their care, they cited not knowing where to go for treatment more often than white people.

And while cost has not been reported as a significant barrier to treatment, additional evidence suggests otherwise. “The high cost of mental health care in the United States remains a challenge faced by many people seeking care, and which disproportionately affects people of color, including Asian Americans,” adds Yang.

“Much of the literature cites stigma as a major contributor to the disparity in mental health care,” Yang adds. “While this is certainly a contributing factor, there are by far systemic factors that contribute to the lack of treatment in mental health.”

The experience of a supplier

Timothy Lo, LCSW, psychotherapist in Chicago, says the Athenahealth report helps contextualize long-term issues. “The question is, do Asian Americans get diagnosed at a higher or lower rate depending on who they are, or what system they are part of?”

Lo says the answer is the last. Yang’s study, he adds, further contextualizes the issues. “Part of this is just the use, which Asian Americans are less likely to ask for help even though they know it’s there, even if they need it.”

In general, this corresponds to his anecdotal experience as a clinician. “In Asian populations, like most immigrant populations in the United States, access to mental health services is more stigmatized,” he says. Among his Asian clients, he sees a lack of recognition around the topic of mental health, especially among immigrants who did not grow up in the United States.

There may also be a language barrier, as a minority of therapists speak Cantonese or Mandarin. “This has occurred to me on several occasions, where people have contacted me because they are desperately trying to find a therapist for themselves or family members who actually want to use the services, but their English is not there. not good enough, ”he said. said. “I can not talk [their language] almost well enough to do clinical work.

And in general, among the Asian customers he sees, they tend to seek him out through insurance. People who do not have or cannot afford insurance cannot find help this way.

How to address these disparities

Mental health care in the United States has been and does not take cultural or language differences into account, Yang says, because the majority of mental health personnel are white individuals.

But that doesn’t mean it can’t change. “The health field is moving in the right direction as cultural competence is now strongly emphasized, more and more individuals from racial / ethnic minorities are entering mental health staff and efforts such as Project All of Us are in the process of including more diverse samples of research study participants, ”Yang says. “However, we still have a long way to go before any form of fairness can be achieved.”

When considering what needs to change to reduce disparities, Lo says it starts with access. Everyone who needs to access care should get it, removing all barriers including lack of multicultural providers, cost, planning and location. “It would mean a huge change in multiple ways across the mental health field,” he says. It would also involve universal health care, he adds.

In an ideal world, Yang says, the United States would achieve mental health equity, not just equality, by establishing a system where everyone gets what they specifically need to live healthy, fulfilling lives. “This includes not only access to mental health care, but also to food, shelter, work and other basic human needs that inevitably impact our mental health,” she says.

Source link

]]> 0